GLAXO WELLCOME MANUFACTURING PTE LTD.
GLAXO WELLCOME MANUFACTURING PTE LTD. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130143931 | 5-[5-[2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-2-METHYLPROPANOMETHYLPROPANOYLMET- HYLAMINO]-4-(4-FLUORO-2-METHYLPHENYL)]-2-PYRIDINYL-2-ALKYL-PROLINAMIDE AS NK1 RECEPTOR ANTAGONISTS - The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is C | 06-06-2013 |
20130123250 | SPIRO (PIPERIDINE-4,2'-PYRROLIDINE)-1-(3,5-TRIFLUOROMETHYLPHENYL) METHYLCARBOXAMIDES AS NK1 TACHIKYNIN RECEPTOR ANTAGONISTS - Compounds of formula (I) or pharmaceutically acceptable salts thereof | 05-16-2013 |
20130023550 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME - Pharmaceutical compositions that include about 10 mg pazopanib/mL of the composition and about 2 to about 13% w/w of a modified cyclodextrin as well as methods of making the same are described. | 01-24-2013 |
20120165354 | TREATMENT METHOD - The present invention relates to methods of treating age-related macular degeneration in a patient by administration of pazopanib or pharmaceutically acceptable salts or solvates thereof. | 06-28-2012 |
20120028918 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME - The present invention relates to pharmaceutical compositions that include about 10 mg pazopanib/mL of the composition and about 2 to about 13% w/w of a modified cyclodextrin as well as methods of making the same are described. | 02-02-2012 |
20110281901 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME - Pharmaceutical compositions that include an amount of an acid addition salt of pazopanib equivalent to about 5 mg/mL pazopanib, about 2.0 to about 13.0% w/w of a modified cyclodextrin suitable for use in an ophthalmic formulation, and pH adjusting agent as well as methods of making the same are described. | 11-17-2011 |